Skip to main content
Erschienen in: Rheumatology International 7/2021

06.10.2020 | Observational Research

Diagnosis and management of gout by clinicians in Nepal: a web-based survey

verfasst von: Binit Vaidya, Kalpana Pudasaini, Rikesh Baral, Shweta Nakarmi

Erschienen in: Rheumatology International | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Patients with gout in Nepal are usually attended by medical graduates, family medicine, internists, and orthopedic surgeons. The study aimed to evaluate knowledge, attitude, and practice (KAP) of point-of-care clinicians of Nepal regarding diagnosis and management of gout and assess the quality of treatment provided to the patients. A web-based descriptive, cross-sectional study was conducted among doctors managing gout patients. The questionnaire comprises 38 multiple choice questions; 9 questions for demographic data, 8, 11, and 10 questions each for knowledge, attitude, and practice, respectively. A pilot study was conducted to observe comprehensibility of the questionnaire before subjecting it to the participants. Ethical approval was obtained from review committee of National Center for Rheumatic diseases, Nepal. Simple descriptive statistics was used to describe the correct responses. Among 1200 clinicians invited, 32% (380) participated in the survey. Maximum respondents were of age group 25–45 years (82%) with majority being internists (43%). Although only 32% understood that the disease is not curable, knowledge regarding disease was acceptable in majority (60–90%). Around 83% denied attending any gout-related seminars and 34% denied being updated with the recent guidelines. The majority of postgraduates (72%) managed the cases themselves. Although there was acceptable practice accuracy on use of therapy for acute attacks (75%), target urate levels (57%), and use of urate-lowering agents (92%), they lacked in adequate screening of co-morbidities and initiation of long-term treatment. The point-of-care clinicians have adequate knowledge to diagnose and treat acute events. However, there is poor reflection in practice and frequent update of treatment guidelines is warranted.
Literatur
1.
Zurück zum Zitat Roddy E, Choi HK (2014) Epidemiology of gout. Rheum Dis Clin N Am 40(2):155–175CrossRef Roddy E, Choi HK (2014) Epidemiology of gout. Rheum Dis Clin N Am 40(2):155–175CrossRef
2.
Zurück zum Zitat Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649–662CrossRef Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649–662CrossRef
3.
Zurück zum Zitat Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63(10):3136–3141CrossRef Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63(10):3136–3141CrossRef
4.
Zurück zum Zitat Wijnands JM, Viechtbauer W, Thevissen K, Arts ICW, Dagnelie PC, Stehouwer CDA, van der Linden S, Boonen A (2015) Determinants of the prevalence of gout in the general population: a systematic review and meta-regression. Eur J Epidemiol 30(1):19–33CrossRef Wijnands JM, Viechtbauer W, Thevissen K, Arts ICW, Dagnelie PC, Stehouwer CDA, van der Linden S, Boonen A (2015) Determinants of the prevalence of gout in the general population: a systematic review and meta-regression. Eur J Epidemiol 30(1):19–33CrossRef
6.
Zurück zum Zitat Rubio-Guerra AF, Morales-Lopez H, Garro-Almendaro AK, Vargas-Ayala G, Duran-Salgado MB, Huerta-Ramirez S, Lozano-Nuevo JJ (2017) Circulating levels of uric acid and risk for metabolic syndrome. Curr Diabetes Rev 13(1):87–90CrossRef Rubio-Guerra AF, Morales-Lopez H, Garro-Almendaro AK, Vargas-Ayala G, Duran-Salgado MB, Huerta-Ramirez S, Lozano-Nuevo JJ (2017) Circulating levels of uric acid and risk for metabolic syndrome. Curr Diabetes Rev 13(1):87–90CrossRef
7.
Zurück zum Zitat Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41(6):1183–1190CrossRef Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41(6):1183–1190CrossRef
8.
Zurück zum Zitat Khanna D, Fitzgerald JD, Khanna PP et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 64(10):1431–1446CrossRef Khanna D, Fitzgerald JD, Khanna PP et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 64(10):1431–1446CrossRef
9.
Zurück zum Zitat Khanna D, Khanna PP, Fitzgerald JD et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 64(10):1447–1461CrossRef Khanna D, Khanna PP, Fitzgerald JD et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 64(10):1447–1461CrossRef
13.
Zurück zum Zitat Cho H, LaRose R (1999) Privacy issues in internet surveys. Soc Sci Comput Rev 17:421–434CrossRef Cho H, LaRose R (1999) Privacy issues in internet surveys. Soc Sci Comput Rev 17:421–434CrossRef
17.
Zurück zum Zitat Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F, Punzi L, So AK, Bardin T (2012) Gout: why is this curable disease so seldom cured? Ann Rheum Dis 71(11):1765–1770CrossRef Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F, Punzi L, So AK, Bardin T (2012) Gout: why is this curable disease so seldom cured? Ann Rheum Dis 71(11):1765–1770CrossRef
18.
Zurück zum Zitat De Vera MA, Marcotte G, Rai S, Galo GS, Bhole V (2014) Medication adherence in gout: a systematic review. Arthritis Care Res (Hoboken) 66(10):1551–1559CrossRef De Vera MA, Marcotte G, Rai S, Galo GS, Bhole V (2014) Medication adherence in gout: a systematic review. Arthritis Care Res (Hoboken) 66(10):1551–1559CrossRef
19.
Zurück zum Zitat Li Q, Li X, Wang J et al (2019) Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open 9(8):e026677CrossRef Li Q, Li X, Wang J et al (2019) Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open 9(8):e026677CrossRef
21.
Zurück zum Zitat Chua XHJ, Lim S, Lim FP, Lim YNA, He H, Teng GG (2018) Factors influencing medication adherence in patients with gout: a descriptive correlational study. J Clin Nurs 27(1–2):e213–e222CrossRef Chua XHJ, Lim S, Lim FP, Lim YNA, He H, Teng GG (2018) Factors influencing medication adherence in patients with gout: a descriptive correlational study. J Clin Nurs 27(1–2):e213–e222CrossRef
22.
Zurück zum Zitat Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 350(11):1093–1103CrossRef Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 350(11):1093–1103CrossRef
Metadaten
Titel
Diagnosis and management of gout by clinicians in Nepal: a web-based survey
verfasst von
Binit Vaidya
Kalpana Pudasaini
Rikesh Baral
Shweta Nakarmi
Publikationsdatum
06.10.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 7/2021
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-020-04712-3

Weitere Artikel der Ausgabe 7/2021

Rheumatology International 7/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.